Apolipoprotein E genotype and its pathological correlation in Chinese Alzheimer's disease with late onset

Human Pathology

Volumn 30, Issue 10, 1999, Pages 1172-1177

  Chen, Lan ^a   Baum, Larry ^a   Ng, Ho Keung ^a,b   Chan, Lisa Y S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Alzheimer's disease; Apolipoprotein E; Neurofibrillary tangle; Possible AD; amyloid plaque

Indexed keywords

APOLIPOPROTEIN E; DNA;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CHINESE; CLINICAL ARTICLE; DEMENTIA; ETHNIC GROUP; GENOTYPE; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; ONSET AGE; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0032837130     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90034-5     Document Type: Article

References (35)

1. Saunders AM, Hulette O, Weish-Bohmer KA, et al: Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 348:90-93, 1996
2. Mirra SS, Heyman A, McKeel D, et al: The consortium to establish a registroy for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486, 1991
3. Mirra SS, Hart MN, Terry RD: Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 117:132-144, 1993
4. Hyman BT, Trojanowski JQ: Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 56:1095-1097, 1997
5. Wasco W, Tanzi RE: Molecular mechanisms of dementia. Totowa, New Jersey, Humana Press, 1997, pp 21-37
6. Polvikoski T, Sulkava R, Haltia M, et al: Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 333:1242-1247, 1995
7. Schmechel DE, Saunders AM, Strittmatter WJ, et al: Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 90:9649-9653, 1993
8. Berg L, McKeel DW, Miller JP, et al: Clinicopathologic studies in cognitively healthy aging and Alzheimer disease. Arch Neurol 55:326-335, 1998
9. Gomez-Isla T, West HL, Rebeck GW, et al: Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 39:62-70, 1996
10. Itoh Y, Yamada M, Polvikoski T, et al: Apolipoprotein E and the neuropathology of dementia. N Engl J Med 334:599-600, 1996
11. Landen M, Thorsell A, Wallin A, et al: The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 61:352-356, 1996
12. Pirttilä T, Soininen H, Mehta PD, et al: Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiology of Aging 18:121-127, 1997
13. Chiu HFK, Lam LCW, Chi I, et al: Prevalence of dementia in Chinese elderly in Hong Kong. Neurology 50:1002-1009, 1997
14. Zhang MY, Katzman R, Salmon D, et al: The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender and education. Ann Neurol 27:428-437, 1990
15. Evans DA, Funkenstein HH, Albert MS, et al: Prevalence of Alzheimer's disease in a community population of older persons: Higher than previously reported (see comments). JAMA 262:2551-2556, 1989
16. Rocca WA, Hofman A, Brayne C, et al: Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980-1990 prevalence findings: The EURODEM-Prevalence Research Group. Ann Neurol 30:381-390, 1991
17. Ng HK: Alzheimer's disease and Alzheimer-type of cerebral degenerations in Chinese. Clin Exp Neurol 31:85-98, 1994
18. Ng HK, Lee JCK: Degenerative cerebral alterations in Chinese aged 65 years or older. Clin Neuropathol 7:280-284, 1988
19. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259, 1991
20. Sambrook J, Eritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, (ed 2). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989, pp E3-E4, E10-E11, B.16
21. Kontula K, Aalto-Setala K, Kuusi T, et al: Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: Convenient alternative to phenotyping by isoelectric focusing. Clin Chem 36:2087-2092, 1990
22. Farrer LA, Cupples LA, Haines JL, et al: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 278:1349-1356, 1997
23. Corder EH, Saunders AM, Risch NJ, et al: Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet 7:180-184, 1994
24. Van Duijin C, de Knijff P, Wehnert A, et al: The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann Neurol 37:605-610, 1995
25. Sorbi S, Nacmias B, Forleo P, et al: ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci Lett 177:100-102, 1994
26. Mak YT, Chiu H, Woo J, et al: Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 46:146-149, 1996
27. Hallman DM, Boerwinkle E, Saha N, et al: The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations. Am J Hum Genet 49:338-349, 1991
28. Nalbantoglu J, Gilfix B, Bertrand P, et al: Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies. Ann Neurol 36:889-895, 1994
29. Ng HK, Cheng Y, Poon WS: Alzheimer-type of pathological changes in Chinese. J Neurol Sci 145:97-103, 1997
30. Heimer L: The Human Brain and Spinal Cord: Functional Neuroanatomy and Dissection Guide (ed 2). New York, NY, Springer-Verlag, 1998, pp 415-431
31. Arnold SE, Hyman BT, Flory J, et al: The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1:103-116, 1991
32. Lippa CR, Smith TW, Sauders AM, et al: Apolipoprotein E-∈2 and Alzheimer's disease: Genotype influences pathologic phenotype. Neurology 48:515-519, 1997
33. Strittmatter WJ, Weisgraber KH, Huang DY, et al: Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102, 1993
34. Sanan DA, Weigraber KH, Russell SJ, et al: Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils: Isoform ApoE 4 associates more efficiently than ApoE 3. J Clin Invest 94:860-869, 1994
35. Hulette CM, Welsh-Bohmer KA, Murray MG, et al: Neuropathological and neuropsychological changes in "normal" aging: Evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 57:1168-1174, 1998